Corbus Pharmaceuticals Holdings, Inc.: updates investor presentation

What happened

• Corbus Pharmaceuticals Holdings, Inc. reported on Oct 15, 2026 that it updated its presentation used by management to describe its business and furnished a copy of the presentation as Exhibit 99.1 to the Current Report on Form 8-K.

Key details

• Item reported: Item 7.01, Regulation FD Disclosure.
• Presentation furnished as: Exhibit 99.1.
• Form 8-K filed and signed on Oct 15, 2026 by Yuval Cohen, Chief Executive Officer.

Why it may matter

• Item 7.01 covers Regulation FD disclosures, which is used to make certain information public; the filing states that the updated investor presentation was furnished and incorporated by reference into the Form 8-K.
• This filing does not show why an insider traded or why the company acted.